Radio-guided ultrasound lymph node localization: Feasibility of a new technique for localizing and excising nonpalpable lymph nodes ultrasound suspicious for melanoma metastases

Melanoma Research

Volumn 20, Issue 3, 2010, Pages 197-202

  Testori, Alessandro ^a   Rastrelli, Marco ^a,f   De Fiori, Elvio ^b   Soteldo, Javier ^a   Vigna, Paolo Della ^b   Trifirò, Giuseppe ^c   Mazzarol, Giovanni ^d   Travaini, Laura Lavinia ^c   Verrecchia, Francesco ^a   Ratto, Enrico Luigi ^a   Bellomi, Massimo ^b,e  

^a Division of Melanoma and Sarcoma   (Italy)

^b Department of Radiology ^*  (Italy)

^c Division of Nuclear Medicine   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Melanoma follow up; Radio guided occult lesion localization; Radio guided ultrasound lymph node localization; Ultrasound lymph node evaluation

Indexed keywords

HUMAN SERUM ALBUMIN TC 99M; SERUM ALBUMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; HODGKIN DISEASE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOMA; PRIORITY JOURNAL; SCINTIGRAPHY; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION; BIOPSY; LYMPH NODE; METABOLISM; METASTASIS; MIDDLE AGED; ONCOLOGY; PATHOLOGY; PROCEDURES; RADIOGRAPHY; SKIN TUMOR; ULTRASOUND;

ADULT; BIOPSY; FEMALE; HUMANS; LYMPH NODES; MALE; MEDICAL ONCOLOGY; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SERUM ALBUMIN; SKIN NEOPLASMS; ULTRASONICS; ULTRASONOGRAPHY;

EID: 77952242310     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3283350527     Document Type: Article

References (20)

1. Markovic SN, Erickson LA, Rao RD, Weening RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007;82:364-380.
2. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Rointgen DS, Cascinelli N, et al. Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634.
3. Kim SH, Garcia C, Rodriguez J, Coit DG. Prognosis of thick cutaneous melanoma. J Am Coll Surg 1999;188:241-247.
4. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
5. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
6. Eggermont AM, Voit C. Management of melanoma: a European perspective. Surg Oncol Clin N Am 2008;17:635-648.
7. Hocevar M, Bracko M, Pogacnik A, Vidergar-Kralj B, Besic N, Zgajnar J, et al. The role of preoperative ultrasonography in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res 2004;14:533-536.
8. Voit C, Kron M, Schafer G, Schoengen A, Audring H, Lukowsky A, et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 2006;13:1682-1689.
9. Landercasper J, Gundersen SB Jr, Gundersen AL, Cogbill TH, Travelli R, Strutt P. Needle localization and biopsy of nonpalpable lesions of the breast. Surg Gynecol Obstet 1987;164:399-403.
10. Silverstein MJ, Gamagami P, Rosser RJ, Gierson ED, Colburn WJ, Handel N, et al. Hooked-wire-directed breast biopsy and overpenetrated mammography. Cancer 1987;59:715-722.
11. Meloni GB, Becchere MP, Soro D, Profili S, Canalis GC. Localization of nonpalpable lesions of the breast using a metallic guide. Potential complications. Radiol Med 1995;89:619-622.
12. Gennari R, Galimberti V, De Cicco C, Zurrida S, Zerwes F, Pigatto F, et al. use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. J Am Coll Surg 2000;190:692-698.
13. Paganelli G, Veronesi U. Innovation in early breast cancer surgery: radioguided occult lesion localization and sentinel node biopsy. Nucl Med Commun 2002;7:625-627.
14. Paganelli G, Luini A, Veronesi U. Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. Ann Oncol 2002;13:1839-1840.
15. De Cicco C, Trifirò G, Intra M, Marotta G, Ciprian A, Frasson A, et al. Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol Imaging 2004;31:349-354.
16. Van Esser S, Hobbelink M, Van der Ploeg IM, Mali WP, Van Diest PJ, Borel Rinkes IH, et al. Radio guided occult lesion localization (ROLL) for non-palpable invasive breast cancer. J Surg Oncol 2008;98:526-529.
17. Testori A, Lazzaro G, Baldini F, Tosti G, Mosconi M, Lovati E, et al. The role of ultrasound of sentinel nodes in the pre-and post-operative evaluation of stage I melanoma patients. Melanoma Res 2005;15:191-198.
18. Bryant JA, Siddiqi NJ, Loveday EJ, Irvine GH. Presurgical, ultrasound-guided anchor-wire marking of impalpable cervical lymph nodes. J Laryngol Otol 2005;8:627-628.
19. Scolyer RA, Thompson JF, Li LX, Beavis A, Dawson M, Doble P, et al. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 2004;17:1191-1197.
20. Cremonesi M, Ferrari M, Sacco E, Rossi A, De Cicco C, Leonardi L, et al. Radiation protection in radioguided surgery of breast cancer. Nucl Med Commun 1999;20:919-924.